Literature DB >> 24898105

The therapeutic effect of UDCA is a factor in determining the prognosis of primary biliary cirrhosis.

Mikio Zeniya1, Takashi Wada.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24898105     DOI： 10.1007/s00535-014-0969-4

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN： 0944-1174            Impact factor:   7.527


× No keyword cloud information.
  9 in total

1.  Baseline ductopenia and treatment response predict long-term histological progression in primary biliary cirrhosis.

Authors:  Teru Kumagi; Maha Guindi; Sandra E Fischer; Tamara Arenovich; Rupert Abdalian; Catalina Coltescu; E Jenny Heathcote; Gideon M Hirschfield
Journal:  Am J Gastroenterol       Date:  2010-05-25       Impact factor: 10.864

2.  Long-term effects of mid-dose ursodeoxycholic acid in primary biliary cirrhosis: a meta-analysis of randomized controlled trials.

Authors:  Jian Shi; Cheng Wu; Yong Lin; Yue-Xiang Chen; Liang Zhu; Wei-fen Xie
Journal:  Am J Gastroenterol       Date:  2006-07       Impact factor: 10.864

3.  Guidelines for the management of primary biliary cirrhosis: The Intractable Hepatobiliary Disease Study Group supported by the Ministry of Health, Labour and Welfare of Japan.

Authors: 
Journal:  Hepatol Res       Date:  2014-01       Impact factor: 4.288

4.  Ursodeoxycholic acid and primary biliary cirrhosis: EASL and AASLD guidelines.

Authors:  Emmanuel A Tsochatzis; Kurinchi S Gurusamy; Christian Gluud; Andrew K Burroughs
Journal:  J Hepatol       Date:  2009-10-07       Impact factor: 25.083

5.  Biochemical response to ursodeoxycholic acid predicts survival in a North American cohort of primary biliary cirrhosis patients.

Authors:  Craig Lammert; Brian D Juran; Erik Schlicht; Landon L Chan; Elizabeth J Atkinson; Mariza de Andrade; Konstantinos N Lazaridis
Journal:  J Gastroenterol       Date:  2013-12-08       Impact factor: 7.527

6.  Excellent long-term survival in patients with primary biliary cirrhosis and biochemical response to ursodeoxycholic Acid.

Authors:  Albert Parés; Llorenç Caballería; Juan Rodés
Journal:  Gastroenterology       Date:  2006-03       Impact factor: 22.682

Review 7.  Ursodeoxycholic acid for primary biliary cirrhosis.

Authors:  Yan Gong; Zhi Bi Huang; Erik Christensen; Christian Gluud
Journal:  Cochrane Database Syst Rev       Date:  2008-07-16

8.  Waiting list mortality of patients with primary biliary cirrhosis in the Japanese transplant allocation system.

Authors:  Takuya Genda; Takafumi Ichida; Shotaro Sakisaka; Michio Sata; Eiji Tanaka; Ayano Inui; Hiroto Egawa; Kouji Umeshita; Hiroyuki Furukawa; Seiji Kawasaki; Yukihiro Inomata
Journal:  J Gastroenterol       Date:  2013-03-12       Impact factor: 7.527

9.  Biochemical response to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosis.

Authors:  Christophe Corpechot; Ludovico Abenavoli; Nabila Rabahi; Yves Chrétien; Tony Andréani; Catherine Johanet; Olivier Chazouillères; Raoul Poupon
Journal:  Hepatology       Date:  2008-09       Impact factor: 17.425
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.